McKesson to Buy Precision Medicine Group for $2.25B
McKesson unveiled a $2.25B deal for Precision Medicine Group, doubling down on its fastest-growing segment: Oncology & Multispecialty.
mckesson
McKesson unveiled a $2.25B deal for Precision Medicine Group, doubling down on its fastest-growing segment: Oncology & Multispecialty.